Center Laboratories, Inc. (TPEX: 4123)
Taiwan
· Delayed Price · Currency is TWD
40.55
+0.05 (0.12%)
Jan 20, 2025, 1:30 PM CST
Center Laboratories Revenue
Center Laboratories had revenue of 392.49M TWD in the quarter ending September 30, 2024, with 15.04% growth. This brings the company's revenue in the last twelve months to 1.57B, up 28.33% year-over-year. In the year 2023, Center Laboratories had annual revenue of 1.39B with 81.58% growth.
Revenue (ttm)
1.57B
Revenue Growth
+28.33%
P/S Ratio
18.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
Dec 31, 2020 | 717.05M | -720.63M | -50.12% |
Dec 31, 2019 | 1.44B | -20.21B | -93.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |